About LifeMap Sciences
LifeMap Sciences (“LifeMap”) is a life sciences technology company dedicated to providing the leading edge Integrated Biomedical Knowledgebase. Operations worldwide are carried out from its offices in California, Massachusetts, New Jersey, Tel Aviv and Hong Kong. LifeMap is a subsidiary of BioTime, Inc.
LifeMap’s Integrated Biomedical Knowledgebase and discovery platform for biomedical research currently includes GeneCards®: the leading human gene database; LifeMap Discovery®, the database of embryonic development, stem cell research and regenerative medicine; MalaCards, the human disease database; and GeneAnalytics™, a novel gene set analysis tool which leverages our Integrated Biomedical Knowledgebase. LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biotechnology and pharmaceutical companies.
LifeMap intends to continually improve the quality of its products, and is pursuing several new Internet and informatics products with substantial, rapid-revenue growth potential, leveraging its existing products and their large user base of life scientists. LifeMap also intends to extend its offerings to the field of mobile health via its subsidiary LifeMap Solutions, Inc.
Latest News
-
Jan 15, 2015
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect.LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in identifying the roles of genes and their variants in biological processes, health, and disease.